Trimethobenzamide is a novel antiemetic which prevents nausea and vomiting in humans. Its actions are unclear but most likely involves the chemoreceptor trigger zone (CTZ). In dogs pretreated with trimethobenzamide HCl, the emetic response to apomorphine is inhibited, while little or no protection is afforded against emesis induced by intragastric copper sulfate. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Ametik damla, Tebamide, Tribenzagan, Benzacot and emedur. Its PubChem CID is 5577.
Trimethobenzamide
| CAS No | 138-56-7 |
|---|---|
| Molecular Formula | C21H28N2O5 |
| Molecular Weight | 388.5 g/mol |
| Synonyms | N-[[4-[2-(dimethylamino)ethoxy]phenyl]methyl]-3,4,5-trimethoxybenzamide |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Trimethobenzamide is a novel antiemetic which prevents nausea and vomiting in humans. Its actions are unclear but most likely involves the chemoreceptor trigger zone (CTZ).
The listed CAS number is 138-56-7.
The listed molecular formula is C21H28N2O5.
The listed molecular weight is 388.5 g/mol.
N-[[4-[2-(dimethylamino)ethoxy]phenyl]methyl]-3,4,5-trimethoxybenzamide.
The source lists Ametik damla, Tebamide, Tribenzagan, Benzacot and emedur.